Fig. 1From: Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: a randomized controlled trialPatient disposition. One patient withdrew consent before receiving study drug on Day 1 and was excluded from all analyses (safety and efficacy). CCH, collagenase clostridium histolyticumBack to article page